The global biologics for systemic lupus erythematosus market is estimated to reach at a value of US$ 2.5 Bn by the end of 2022 and expected to reach at a value of US$ 4.3 Bn by 2030 with a significant CAGR of 6.8%.
The global blood plasma market in 2020 is estimated for more than US$ 21.1 Bn and expected to reach at a value of US$ 35.4 Bn by 2028 with a significant CAGR of 6.7%.
The Immunoglobulins Market is estimated to grow from USD 11.7 billion in 2020 to USD 16.8 billion by 2026 at a healthy CAGR of 6.3% during the forecast period.